Alliance Pharma Equity 2024

Alliance Pharma Aktienanalyse

What does Alliance Pharma do?

Alliance Pharma PLC is a globally operating pharmaceutical company specializing in the marketing and development of pharmaceutical products. The company is headquartered in the United Kingdom and was founded in 1996. Alliance Pharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Alliance Pharma's Equity

Alliance Pharma's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Alliance Pharma's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Alliance Pharma's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Alliance Pharma's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Alliance Pharma’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Alliance Pharma stock

What is the equity of Alliance Pharma this year?

Alliance Pharma has equity of 217.87 M GBP this year.

What was the equity of Alliance Pharma compared to the previous year?

The equity of Alliance Pharma has increased/decreased by -17.94% decreased compared to the previous year.

What impact does a high equity have on investors of Alliance Pharma?

A high equity is advantageous for investors of Alliance Pharma as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Alliance Pharma?

A low equity can be a risk for investors of Alliance Pharma, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Alliance Pharma affect the company?

An increase in equity of Alliance Pharma can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Alliance Pharma affect the company?

A reduction in equity of Alliance Pharma can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Alliance Pharma?

Some factors that can affect the equity of Alliance Pharma include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Alliance Pharma so important for investors?

The equity of Alliance Pharma is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Alliance Pharma take to change the equity?

To change equity, Alliance Pharma can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Alliance Pharma pay?

Over the past 12 months, Alliance Pharma paid a dividend of 0.02 GBP . This corresponds to a dividend yield of about 5.54 %. For the coming 12 months, Alliance Pharma is expected to pay a dividend of 0.02 GBP.

What is the dividend yield of Alliance Pharma?

The current dividend yield of Alliance Pharma is 5.54 %.

When does Alliance Pharma pay dividends?

Alliance Pharma pays a quarterly dividend. This is distributed in the months of January, July, January, July.

How secure is the dividend of Alliance Pharma?

Alliance Pharma paid dividends every year for the past 0 years.

What is the dividend of Alliance Pharma?

For the upcoming 12 months, dividends amounting to 0.02 GBP are expected. This corresponds to a dividend yield of 5.59 %.

In which sector is Alliance Pharma located?

Alliance Pharma is assigned to the 'Health' sector.

Wann musste ich die Aktien von Alliance Pharma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Alliance Pharma from 7/18/2023 amounting to 0.012 GBP, you needed to have the stock in your portfolio before the ex-date on 6/22/2023.

When did Alliance Pharma pay the last dividend?

The last dividend was paid out on 7/18/2023.

What was the dividend of Alliance Pharma in the year 2023?

In the year 2023, Alliance Pharma distributed 0.017 GBP as dividends.

In which currency does Alliance Pharma pay out the dividend?

The dividends of Alliance Pharma are distributed in GBP.